MedPath
HSA Approval

PARALDEHYDE INJECTION BP

SIN00325P

PARALDEHYDE INJECTION BP

PARALDEHYDE INJECTION BP

April 22, 1988

PHEBRA (SE ASIA) PTE. LTD.

PHEBRA (SE ASIA) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHEBRA (SE ASIA) PTE. LTD.
Licence HolderPHEBRA (SE ASIA) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAMUSCULAR

Medical Information

N05CC05

paraldehyde

Manufacturer Information

PHEBRA (SE ASIA) PTE. LTD.

HOSPIRA AUSTRALIA PTY LTD

Active Ingredients

PARALDEHYDE

5 ml/ampoule

Paraldehyde

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.